These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 5577527)

  • 1. [Prevention of hemorrhagic and thromboembolic complications in heart valve prosthesis].
    Pospelova EP; Stepanian EP; Shchurkalina TKh; Movsesian RA
    Grudn Khir; 1971; 13(1):49-51. PubMed ID: 5577527
    [No Abstract]   [Full Text] [Related]  

  • 2. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of thromboembolism following heart valve replacement].
    van de Loo J; Stenzinger W
    Verh Dtsch Ges Inn Med; 1989; 95():275-82. PubMed ID: 2690497
    [No Abstract]   [Full Text] [Related]  

  • 4. [A study on anticoagulations and thromboembolic complication in aortic and double valve replacement with Starr-Edwards ball valve prostheses (author's transl)].
    Sakashita I; Nakamura C; Ohtani S; Asano K
    Nihon Kyobu Geka Gakkai Zasshi; 1977 Nov; 25(11):1470-5. PubMed ID: 609012
    [No Abstract]   [Full Text] [Related]  

  • 5. High complication and failure rates of anticoagulant therapy are avoidable.
    Broekmans AW; Loeliger EA
    Z Kardiol; 1986; 75 Suppl 2():298-301. PubMed ID: 3727706
    [No Abstract]   [Full Text] [Related]  

  • 6. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
    Acar J
    J Heart Valve Dis; 1993 Jul; 2(4):395-7. PubMed ID: 8269141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of thromboembolism in heart valve diseases and following heart valve replacement].
    Stenzinger W; van de Loo J
    Internist (Berl); 1989 Aug; 30(8):520-4. PubMed ID: 2676892
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.
    Gohlke-Bärwolf C; Acar J; Burckhardt D; Oakley C; Butchart E; Krayenbühl P; Hall R; Bodnar E; Krzeminska-Pakula M; Delahaye JP
    J Heart Valve Dis; 1993 Jul; 2(4):398-410. PubMed ID: 8269142
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulant treatment of patient with the substitute heart valve].
    Halinen MO; Lassila R
    Duodecim; 2000; 116(2):157-65. PubMed ID: 11764475
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beall prosthesis. Its use in the surgical treatment of mitral valve diseases].
    Goudard A; Monties JR; Baille Y; Jausseran JM; Sicard MP; Avierinos C; Henry E
    Nouv Presse Med; 1972 Apr; 1(16):1069-72. PubMed ID: 5035862
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
    Cortelazzo S; Finazzi G; Viero P; Galli M; Remuzzi A; Parenzan L; Barbui T
    Thromb Haemost; 1993 Apr; 69(4):316-20. PubMed ID: 8497842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for post-discharge patient follow up after cardiac valve interventions: a position paper.
    Horstkotte D; Lengyel M; Mistiaen WP; Völler H; Reibis R; Bogunovic N; Faber L; Hering D; Piper C; ;
    J Heart Valve Dis; 2007 Nov; 16(6):575-89. PubMed ID: 18095504
    [No Abstract]   [Full Text] [Related]  

  • 18. Katarcioglu SF, Yamak B, Ulus AT, Tasdemir O, Bayazit K. Mitral valve replacement with St. Jude Medical prosthesis and low-dose anticoagulation in patients aged over 50 years. J. Heart Valve Dis 1998;7:455-459.
    Sierra-Quiroga J; Rubio-Alvarez J; Duran-Munoz D; Garcia-Bengochea JB
    J Heart Valve Dis; 1999 Mar; 8(2):232-3. PubMed ID: 10224585
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anticoagulant treatment in patients with artificial heart valves].
    Skarzyńska M
    Kardiol Pol; 1976; 19(3):259-64. PubMed ID: 966418
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outpatient care, of patients with artificial heart valve (author's transl)].
    Dziatkowiak A; Tracz W; Moll J; Zaslonka J
    Przegl Lek; 1974; 31(5):526-31. PubMed ID: 4849332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.